DUBLIN, Oct. 29, 2015 /PRNewswire/ — Research and Markets ( http://www.researchandmarkets.com/research/gqh7px/global_stem_cell) has announced the addition of the “Global Stem Cell Banking Market 2015-2019” report to their offering. The global stem ...
NeoStem to Present at Two Upcoming Investor Conferences in March New York, March 12, 2015 - NeoStem, Inc. (NASDAQ:NBS) ("NeoStem" or the "Company"), a biopharmaceutical company developing novel cell based ...
New York, March 3, 2015 -- NeoStem, Inc. (Nasdaq:NBS) ("NeoStem" or the "Company"), a biopharmaceutical company developing novel, cell-based personalized medicine therapies, announced today 2014 year end results and provided ...
Stem Cell Therapeutics Markets Reportby Kalorama Information There are more than 4,000 research projects underway for stem cell therapies throughout the world. Only about a dozen companies worldwide are currently evaluating ...
NeoStem Live in New YorkFebruary 6, 2015 NeoStem to Present at BIO CEO & Investor Conferenceand at Sachs Associates Cancer Bio Partnering& Investment Forum Los Angeles, February 6, 2015 - NeoStem, Inc. ...
NEW YORK, Jan. 22, 2015 (GLOBE NEWSWIRE) -- NeoStem, Inc. (NBS), a leader in the development and manufacturing of cell therapy products and regenerative medicine, today announced the addition of ...
NeoStem Receives Drug Manufacture License for Irvine FacilityLicense Allows Manufacture and Distribution of Eltrapuldencel-T (NBS20) for Clinical Trial UseNEW YORK, Jan. 20, 2015 (GLOBE NEWSWIRE) -- NeoStem, Inc. (NBS) a ...
OverviewNeoStem: NASDAQ:NBSIntegrated biotechnology Company with as strong pipeline based on multiple platform technologies that include Phase 2 and 3 assets and a revenue generating contract development and manufacturing businessFive (5) ...
